OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Board of Trustees of the Leland Stanford Junior University

3 Projects | 2 Researchers | $773,032 Invested

2020

Board of Trustees of the Leland Stanford Junior University

Thomas Montine, MD, PhD

Blood-based immune biomarkers for Alzheimer's disease diagnosis and its early detection

  • Funding Amount: $468,500
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Systemic Inflammation
  • Status: Closed

2005

Board of Trustees of the Leland Stanford Junior University

Tony Wyss-Coray, PhD

The TGF-Beta Pathway as a Therapeutic Target to Treat Alzheimer’s Disease

  • Funding Amount: $152,300
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2003

Board of Trustees of the Leland Stanford Junior University

Tony Wyss-Coray, PhD

The TGF-Beta Pathway as a Therapeutic Target to Treat Alzheimer's Disease

  • Funding Amount: $152,232
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed